DD202-114
DD202-114 is a potent and selective GLP1R agonist. DD202-114 inhibits hERG with an IC50 of 15.9 μM. DD202-114 exhibits strong CYP2C8 inhibition with an IC50 of 0.22 μM. DD202-114 promotes cAMP accumulation. DD202-114 reduces blood glucose levels and food intake. DD202-114 has the potential to be used in the study of type 2 diabetes mellitus (T2DM) and obesity[1][2].
Product Specifications
CAS Number
2886728-09-0
UNSPSC
12352005
Target
Cytochrome P450; GLP Receptor; Potassium Channel
Type
Reference compound
Related Pathways
GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/dd202-114.html
Purity
98.47
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2C(N(C(CN3CCC(C4=NC(OCC5=C(C=C(C=C5)C6COC6)F)=CC=C4)CC3)=N2)C[C@@H]7CCO7)=C1)O
Molecular Formula
C33H35FN4O5
Molecular Weight
586.65
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
DNP Recombinant Monoclonal Rat Antibody (rLO-DNP-2), CF®640R Conjugate - Biotium Choice
